Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,516 | -16,851 | -15,371 | -20,278 | -18,926 |
| Depreciation Amortization | 1,273 | 1,203 | 1,048 | 880 | 1,024 |
| Income taxes - deferred | -27 | -694 | 60 | 61 | 60 |
| Accounts receivable | -1,458 | -337 | -644 | -52 | 826 |
| Other Working Capital | -137 | -5,403 | 520 | -2,550 | -1,604 |
| Other Operating Activity | 7,718 | 3,670 | 3,791 | 4,167 | 2,419 |
| Operating Cash Flow | $-14,147 | $-18,412 | $-10,596 | $-17,772 | $-16,201 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -522 | -747 | -1,414 | -1,778 | -197 |
| Investing Cash Flow | $-522 | $-747 | $-1,414 | $-1,778 | $-197 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | N/A | N/A | 16,875 |
| Debt Issued | 16,196 | N/A | N/A | -42 | N/A |
| Debt Repayment | -3,742 | -146 | -171 | -107 | 0 |
| Common Stock Issued | 3 | 21,764 | 9,521 | 44 | 51,430 |
| Common Stock Repurchased | -164 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,058 | 0 | 0 | 0 | -21,553 |
| Financing Cash Flow | $11,235 | $21,618 | $9,350 | $-105 | $46,752 |
| Exchange Rate Effect | -106 | 262 | -64 | -206 | -234 |
| Beginning Cash Position | 11,896 | 9,175 | 11,899 | 31,560 | 1,440 |
| End Cash Position | 8,356 | 11,896 | 9,175 | 11,699 | 31,560 |
| Net Cash Flow | $-3,540 | $2,721 | $-2,724 | $-19,861 | $30,120 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,147 | -18,412 | -10,596 | -17,772 | -16,201 |
| Capital Expenditure | -558 | -747 | -1,414 | -1,803 | -198 |
| Free Cash Flow | -14,705 | -19,159 | -12,010 | -19,575 | -16,399 |